On advertising & compliance
Why your clinic’s Meta ads broke in 2026
It’s probably not the algorithm. The rules changed, and they broke the old playbook.
Two Australian regulator changes made the creative most clinics were running non-compliant: the TGA’s 7 March 2024 tightening on naming injectables, and AHPRA’s higher-risk non-surgical guideline, effective 2 September 2025. This is general information, not legal advice. Last reviewed 14 June 2026.
The playbook that stopped working
For years the winning aesthetic ad followed a formula. Name the treatment. Show a dramatic before-and-after. Add a patient raving about their results. Maybe a price or a limited-time offer. It worked because it was concrete and aspirational.
Every element of that formula is now a compliance problem. You can’t name a prescription injectable or its price. Testimonials about the clinical result are banned. Before-and-afters have strict conditions and can’t lead with the after. Idealising language is called out by name. So the ads that used to convert started getting disapproved, or kept running but quietly stopped performing.
The two changes behind it
TGA, 7 March 2024. The generic workarounds, “anti-wrinkle injections” and “dermal fillers”, are no longer expressly permitted where a reasonable consumer reads them as promoting a prescription medicine. The naming workaround most clinics relied on became the breach.
AHPRA, 2 September 2025. A stricter guideline for higher-risk non-surgical procedures, binding all registered health practitioners, tightened testimonials, before-and-after images, idealising imagery, and under-18 targeting, and added an adult-content classification requirement for higher-risk ads on social media.
The full breakdown of both, with the regulator sources, is in the 2026 rulebook.
The funnel that still fills the calendar
None of this means Meta ads are dead for clinics. It means the funnel has to be built inside the rules from the first draft. The compliant version looks like this:
- ▸Advertise the consultation and the concern, not the named treatment or its price.
- ▸Use compliant trust assets that build belief without testimonials or named products.
- ▸Lead before-and-after galleries with the before or a composite, with a results-may-vary warning, if you use them at all.
- ▸Send people to a deposit-backed booking, not a lead form your team has to chase.
- ▸Rebuild the tracking so the ad account learns from real bookings, even as the creative gets more careful.
As creative gets more careful, the ad account needs cleaner signal than ever to keep finding the right patients. That’s the attribution side most clinics never fix.
Common questions
Did Meta change something, or is it the regulators?
Mostly the regulators. Meta's enforcement of health and cosmetic advertising did tighten, but the bigger shift is Australian: the TGA's 7 March 2024 tightening on naming injectables, and AHPRA's higher-risk non-surgical guideline that took effect 2 September 2025. Together they made the creative most clinics were running non-compliant, which is why ads that used to convert suddenly stalled or got rejected.
What kind of ads stopped working?
The old winners. Naming the treatment or the brand. Pricing injectables. Glossy before-and-afters led with the after image. Patient testimonials about results. Idealising language like "barbie" or "perfect". Each of those is now a compliance problem, so the ad either gets disapproved or quietly underperforms. If your best-performing creative was built on any of them, that's the gap.
So can clinics still run Meta ads at all?
Yes. The funnel just has to be built differently. You advertise the consultation and the concern instead of the product, use compliant trust assets instead of testimonials and named treatments, and send people to a booking, not a lead form. Done right it still fills the calendar.
I build clinic ad funnels inside these rules.
Compliant creative, a booking that doesn’t leak, and tracking the ad account can learn from. Start with the scorecard.
Take the ScorecardSources